Vitamin D receptor inhibits nuclear factor κb activation by interacting with IκB kinase β protein

Journal of Biological Chemistry

Volumn 288, Issue 27, 2013, Pages 19450-19458

  Chen, Yunzi ^a,b   Zhang, Jing ^c   Ge, Xin ^a   Du, Jie ^a   Deb, Dilip K ^b   Li, Yan Chun ^a,b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CHICAGO   (United States)

^c NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CO-IMMUNOPRECIPITATION EXPERIMENTS; GST PULL-DOWN; NUCLEAR FACTORS; NUCLEAR TRANSLOCATIONS; OVER-EXPRESSION; PROTEIN MAPPING; UP-REGULATION; VITAMIN D RECEPTOR;

ENZYMES; PROTEINS; VITAMINS;

IMMUNOLOGY;

BETA CATENIN; CALCITRIOL; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; I KAPPA B BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; UPREGULATION;

IKKΒ; INFLAMMATION; NF-ΚB; NUCLEAR RECEPTORS; PROTEIN-PROTEIN INTERACTIONS; VITAMIN D;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CALCITRIOL; CELL NUCLEUS; HEK293 CELLS; HUMANS; I-KAPPA B KINASE; MICE; MICE, KNOCKOUT; NF-KAPPA B P50 SUBUNIT; PEPTIDE MAPPING; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CALCITRIOL; TRANSCRIPTION FACTOR RELA;

EID: 84880050173     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.467670     Document Type: Article

References (33)

1. Bonizzi, G., and Karin, M. (2004) The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25, 280-288
2. Nakanishi, C., and Toi, M. (2005) Nuclear factor-αB inhibitors as sensitizers to anticancer drugs. Nat. Rev. Cancer 5, 297-309
3. Oeckinghaus, A., Hayden, M. S., and Ghosh, S. (2011) Crosstalk in NF-κB signaling pathways. Nat. Immunol. 12, 695-708
4. Sakurai, H., Chiba, H., Miyoshi, H., Sugita, T., and Toriumi, W. (1999) IκB kinases phosphorylate NF-κB p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem. 274, 30353-30356
5. Bouillon, R., Carmeliet, G., Verlinden, L., van Etten, E., Verstuyf, A., Luderer, H. F., Lieben, L., Mathieu, C., and Demay, M. (2008) Vitamin D and human health. Lessons from vitamin D receptor null mice. Endocr. Rev. 29, 726-776
6. Haussler, M. R., Whitfield, G. K., Haussler, C. A., Hsieh, J. C., Thompson, P. D., Selznick, S. H., Dominguez, C. E., and Jurutka, P. W. (1998) The nuclear vitamin D receptor. Biological and molecular regulatory properties revealed. J. Bone Miner. Res. 13, 325-349
7. Sutton, A. L., and MacDonald, P. N. (2003) Vitamin D. More than a "bonea-fide" hormone. Mol. Endocrinol. 17, 777-791
8. Pálmer, H. G., González-Sancho, J. M., Espada, J., Berciano, M. T., Puig, I., Baulida, J., Quintanilla, M., Cano, A., de Herreros, A. G., Lafarga, M., and Muñoz, A. (2001) Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signaling. J. Cell Biol. 154, 369-387
9. Yuan, W., Pan, W., Kong, J., Zheng, W., Szeto, F. L., Wong, K. E., Cohen, R., Klopot, A., Zhang, Z., and Li, Y. C. (2007) 1,25-Dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J. Biol. Chem. 282, 29821-29830
10. Sun, J., Kong, J., Duan, Y., Szeto, F. L., Liao, A., Madara, J. L., and Li, Y. C. (2006) Increased NF-κB activity in fibroblasts lacking the vitamin D receptor. Am. J. Physiol. Endocrinol. Metab. 291, E315-322
11. D'Ambrosio, D., Cippitelli, M., Cocciolo, M. G., Mazzeo, D., Di Lucia, P., Lang, R., Sinigaglia, F., and Panina-Bordignon, P. (1998) Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-κB downregulation in transcriptional repression of the p40 gene. J. Clin. Invest. 101, 252-262
12. Riis, J. L., Johansen, C., Gesser, B., Møller, K., Larsen, C. G., Kragballe, K., and Iversen, L. (2004) 1,25(OH)(2)D(3) regulates NF-κB DNA binding activity in cultured normal human keratinocytes through an increase in IκBα expression. Arch. Dermatol. Res. 296, 195-202
13. Deb, D. K., Chen, Y., Zhang, Z., Zhang, Y., Szeto, F. L., Wong, K. E., Kong, J., and Li, Y. C. (2009) 1,25-Dihydroxyvitamin D3 suppresses high glucoseinduced angiotensinogen expression in kidney cells by blocking the NF-κB pathway. Am. J. Physiol. Renal Physiol. 296, F1212-1218
14. Zhang, Z., Yuan, W., Sun, L., Szeto, F. L., Wong, K. E., Li, X., Kong, J., and Li, Y. C. (2007) 1,25-Dihydroxyvitamin D(3) targeting of NF-κB suppresses high glucose-induced MCP-1 expression in mesangial cells. Kidney Int. 72, 193-201
15. Chen, Y., Kong, J., Sun, T., Li, G., Szeto, F. L., Liu, W., Deb, D. K., Wang, Y., Zhao, Q., Thadhani, R., and Li, Y. C. (2011) 1,25-Dihydroxyvitamin D(3) suppresses inflammation-induced expression of plasminogen activator inhibitor-1 by blocking nuclear factor-αB activation. Arch. Biochem. Biophys. 507, 241-247
16. Chen, Y., Liu, W., Sun, T., Huang, Y., Wang, Y., Deb, D. K., Yoon, D., Kong, J., Thadhani, R., and Li, Y. C. (2013) 1,25-Dihydroxyvitamin D promotes negative feedback regulation of TLR signaling via targeting microRNA- 155-SOCS1 in macrophages. J. Immunol. 190, 3687-3695
17. Harant, H., Wolff, B., and Lindley, I. J. (1998) 1,25-dihydroxyvitamin D3 decreases DNA binding of nuclear factor-αB in human fibroblasts. FEBS Lett. 436, 329-334
18. Giarratana, N., Penna, G., Amuchastegui, S., Mariani, R., Daniel, K. C., and Adorini, L. (2004) A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development. J. Immunol. 173, 2280-2287
19. Dong, X., Craig, T., Xing, N., Bachman, L. A., Paya, C. V., Weih, F., McKean, D. J., Kumar, R., and Griffin, M. D. (2003) Direct transcriptional regulation of RelB by 1,25-dihydroxyvitamin D3 and its analogs. Physiologic and therapeutic implications for dendritic cell function. J. Biol. Chem. 278, 49378-49385
20. Yu, X. P., Bellido, T., and Manolagas, S. C. (1995) Down-regulation of NF-κB protein levels in activated human lymphocytes by 1,25-dihydroxyvitamin D3 [published erratum appears in Proc. Natl. Acad. Sci. U.S.A. 1996 Jan 9;93(1): 524]. Proc. Natl. Acad. Sci. U.S.A. 92, 10990-10994
21. Lu, X., Farmer, P., Rubin, J., and Nanes, M. S. (2004) Integration of the NFκB p65 subunit into the vitamin D receptor transcriptional complex. Identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3- stimulated transcription. J. Cell Biochem. 92, 833-848
22. Li, Y. C., Bolt, M. J. G., Cao, L.-P., and Sitrin, M. D. (2001) Effects of vitamin D receptor inactivation on the expression of calbindins and calcium metabolism. Am. J. Physiol. Endocrinol. Metab. 281, E558-E564
23. Zandi, E., Chen, Y., and Karin, M. (1998) Direct phosphorylation of IκB by IKKα and IKKβ. Discrimination between free and NF-κB-bound substrate. Science 281, 1360-1363
24. Mercurio, F., Zhu, H., Murray, B. W., Shevchenko, A., Bennett, B. L., Li, J., Young, D. B., Barbosa, M., Mann, M., Manning, A., and Rao, A. (1997) IKK-1 and IKK-2. Cytokine-activated IκB kinases essential for NF-κB activation. Science 278, 860-866
25. Chen, S., Ni, X. P., Humphreys, M. H., and Gardner, D. G. (2005) 1,25 dihydroxyvitamin D amplifies type a natriuretic peptide receptor expression and activity in target cells. J. Am. Soc. Nephrol. 16, 329-339
26. Tan, X., Wen, X., and Liu, Y. (2008) Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-κB signaling. J. Am. Soc. Nephrol. 19, 1741-1752
27. Alroy, I., Towers, T. L., and Freedman, L. P. (1995) Transcriptional repression of the interleukin-2 gene by vitamin D3. Direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol. Cell Biol. 15, 5789-5799
28. Towers, T. L., and Freedman, L. P. (1998) Granulocyte-macrophage colony-stimulating factor gene transcription is directly repressed by the vitamin D3 receptor. Implications for allosteric influences on nuclear receptor structure and function by a DNA element. J. Biol. Chem. 273, 10338-10348
29. Nishishita, T., Okazaki, T., Ishikawa, T., Igarashi, T., Hata, K., Ogata, E., and Fujita, T. (1998) A negative vitamin D response DNA element in the human parathyroid hormone-related peptide gene binds to vitamin D receptor along with Ku antigen to mediate negative gene regulation by vitamin D. J. Biol. Chem. 273, 10901-10907
30. Polly, P., Herdick, M., Moehren, U., Baniahmad, A., Heinzel, T., and Carlberg, C. (2000) VDR-Alien. A novel, DNA-selective vitamin D(3) receptor-corepressor partnership. FASEB J. 14, 1455-1463
31. Sánchez-Martínez, R., Zambrano, A., Castillo, A. I., and Aranda, A. (2008) Vitamin D-dependent recruitment of corepressors to vitamin D/retinoid X receptor heterodimers. Mol. Cell Biol. 28, 3817-3829
32. Murayama, A., Kim, M.-S., Yanagisawa, J., Takeyama, K., and Kato, S. (2004) Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching. EMBO J. 23, 1598-1608
33. Shah, S., Islam, M. N., Dakshanamurthy, S., Rizvi, I., Rao, M., Herrell, R., Zinser, G., Valrance, M., Aranda, A., Moras, D., Norman, A., Welsh, J., and Byers, S. W. (2006) The molecular basis of vitamin D receptor and β-catenin crossregulation. Mol. Cell 21, 799-809